UBS Group’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.1K | Sell |
26,317
-134,559
| -84% | -$292K | ﹤0.01% | 6393 |
|
|
2025
Q1 | $241K | Buy |
160,876
+112,140
| +230% | +$168K | ﹤0.01% | 5185 |
|
|
2024
Q4 | $245K | Buy |
48,736
+46,889
| +2,539% | +$236K | ﹤0.01% | 5138 |
|
|
2024
Q3 | $14.9K | Sell |
1,847
-11,143
| -86% | -$89.8K | ﹤0.01% | 6320 |
|
|
2024
Q2 | $74.8K | Buy |
12,990
+12,390
| +2,065% | +$71.4K | ﹤0.01% | 5239 |
|
|
2024
Q1 | $7.14K | Hold |
600
| – | – | ﹤0.01% | 6233 |
|
|
2023
Q4 | $11.2K | Buy |
600
+500
| +500% | +$9.35K | ﹤0.01% | 6194 |
|
|
2023
Q3 | $949 | Hold |
100
| – | – | ﹤0.01% | 7061 |
|
|
2023
Q2 | $1.43K | Buy |
+100
| New | +$1.43K | ﹤0.01% | 6841 |
|
|
2022
Q3 | – | Sell |
-414
| Closed | -$5K | – | 9180 |
|
|
2022
Q2 | $5K | Buy |
+414
| New | +$5K | ﹤0.01% | 7801 |
|
|
2022
Q1 | – | Sell |
-2,481
| Closed | -$44K | – | 9122 |
|
|
2021
Q4 | $44K | Buy |
2,481
+2,088
| +531% | +$37K | ﹤0.01% | 5926 |
|
|
2021
Q3 | $12K | Sell |
393
-775
| -66% | -$23.7K | ﹤0.01% | 6600 |
|
|
2021
Q2 | $100K | Buy |
+1,168
| New | +$100K | ﹤0.01% | 4838 |
|